Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deenan Pillay

Showing results (1-10 of 323) with videos related to

Pageof 33
Sort By:
BMJ (Clinical Research Ed.)|November 23, 2021
Independent SAGE replies to <i>The BMJ</i>Deenan Pillay,
Antiviral Therapy|November 13, 2004
Current patterns in the epidemiology of primary HIV drug resistance in North America and EuropeDeenan Pillay
Current Opinion in Infectious Diseases|April 20, 2002
Combination antiviral therapy: but which combination, and why?Deenan Pillay
The Journal of Antimicrobial Chemotherapy|September 14, 2007
The priorities for antiviral drug resistance surveillance and researchDeenan Pillay
Current Opinion in Infectious Diseases|June 25, 2003
Disappointments in the treatment of acute viral infections: what's the problem?Deenan Pillay
Reviews in Medical Virology|November 1, 2002
HIV viral load: the myth of the undetectable?Deenan Pillay
Journal of HIV Therapy|June 27, 2008
Antiretroviral resistance in the developing worldDeenan Pillay
Journal of HIV Therapy|December 13, 2003
Issues in diagnostic testing and monitoring in HIV/viral hepatitis co-infectionSamir Dervisevic, Deenan Pillay
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 12, 2006
Multidrug resistant HIV and rapid progression of disease reported from New YorkDeenan Pillay, John Parry
The Journal of Infectious Diseases|March 3, 2007
Primary HIV Infection, phylogenetics, and antiretroviral preventionDeenan Pillay, Martin Fisher
Pageof 33

Showing results (1-10 of 323) with videos related to

Sort By:
Pageof 33
BMJ (Clinical Research Ed.)|November 23, 2021
Independent SAGE replies to <i>The BMJ</i>Deenan Pillay,
Antiviral Therapy|November 13, 2004
Current patterns in the epidemiology of primary HIV drug resistance in North America and EuropeDeenan Pillay
Current Opinion in Infectious Diseases|April 20, 2002
Combination antiviral therapy: but which combination, and why?Deenan Pillay
The Journal of Antimicrobial Chemotherapy|September 14, 2007
The priorities for antiviral drug resistance surveillance and researchDeenan Pillay
Current Opinion in Infectious Diseases|June 25, 2003
Disappointments in the treatment of acute viral infections: what's the problem?Deenan Pillay
Reviews in Medical Virology|November 1, 2002
HIV viral load: the myth of the undetectable?Deenan Pillay
Journal of HIV Therapy|June 27, 2008
Antiretroviral resistance in the developing worldDeenan Pillay
Journal of HIV Therapy|December 13, 2003
Issues in diagnostic testing and monitoring in HIV/viral hepatitis co-infectionSamir Dervisevic, Deenan Pillay
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 12, 2006
Multidrug resistant HIV and rapid progression of disease reported from New YorkDeenan Pillay, John Parry
The Journal of Infectious Diseases|March 3, 2007
Primary HIV Infection, phylogenetics, and antiretroviral preventionDeenan Pillay, Martin Fisher
Pageof 33